Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGTX
#3321
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-5.22%
Monthly Change
-18.66%
6 month change
-58.87%
Year Change
+142.22%
Previous Close
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Volume
16
Markets
US Stock Market
Healthcare
CGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
News
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone
These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025
Cognition Therapeutics closes $30 million registered direct offering
Cognition Therapeutics stock falls after $30 million direct offering